Keystone Financial Planning’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.82M | Sell |
|
|||||
|
2025
Q2 | $8.8M | Buy |
|
|||||
|
2025
Q1 | $8.87M | Buy |
|
|||||
|
2024
Q4 | $7.71M | Buy |
|
|||||
|
2024
Q3 | $248K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.65M | Sell |
|
|||||
|
2023
Q4 | $1.71M | Sell |
|
|||||
|
2023
Q3 | $1.78M | Sell |
|
|||||
|
2023
Q2 | $1.77M | Sell |
|
|||||
|
2023
Q1 | $9.36M | Sell |
|
|||||
|
2022
Q4 | $9.28M | Buy |
|
|||||
|
2022
Q3 | $7.74M | Buy |
|
|||||
|
2022
Q2 | $10.3M | Buy |
|
|||||
|
2022
Q1 | $10.2M | Buy |
|
|||||
|
2021
Q4 | $10.3M | Sell |
|
|||||
|
2021
Q3 | $9.08M | Buy |
|
|||||
|
2021
Q2 | $9.12M | Buy |
|
|||||
|
2021
Q1 | $8.01M | Buy |
|
|||||
|
2020
Q4 | $8M | Buy |
|
|||||
|
2020
Q3 | $7.3M | Buy |
|
|||||
|
2020
Q2 | $7.47M | Buy |
|
|||||
|
2020
Q1 | $6.65M | Buy |
|
|||||
|
2019
Q4 | $7.56M | Buy |
|
|||||
|
2019
Q3 | $6.81M | Buy |
|
|||||
|
2019
Q2 | $6.28M | Buy |
|
|||||
|
2019
Q1 | $6.52M | Buy |
|
|||||
|
2018
Q4 | $5.08M | Buy |
|
|||||
|
2018
Q3 | $5.31M | Buy |
|
|||||
|
2018
Q2 | $5.27M | Buy |
|
|||||
|
2018
Q1 | $5.1M | Buy |
|
|||||
|
2017
Q4 | $4.58M | Sell |
|
|||||
|
2017
Q3 | $5.41M | Buy |
|
|||||
|
2017
Q2 | $5.65M | Buy |
|
|||||
|
2017
Q1 | $5.46M | Buy |
|
|||||
|
2016
Q4 | $4.65M | Hold |
|
|||||
|
2016
Q3 | $5.21M | Buy |
|
|||||
|
2016
Q2 | $5.19M | Buy |
|
|||||
|
2016
Q1 | $4.78M | Buy |
|
|||||
|
2015
Q4 | $4.75M | Buy |
|
|||||
|
2015
Q3 | $4.52M | Buy |
|
|||||
|
2015
Q2 | $4.75M | Buy |
|
|||||
|
2015
Q1 | $5.09M | Buy |
|
|||||
|
2014
Q4 | $3.17M | Sell |
|
|||||
|
2014
Q3 | $3.42M | Buy |
|
|||||
|
2014
Q2 | $3.97M | Sell |
|
|||||
|
2014
Q1 | $4M | Buy |
|
|||||
|
2013
Q4 | $3.98M | Buy |
|